Loading...
XJPX
7733
Market cap14bUSD
Dec 05, Last price  
2,027.50JPY
1D
-0.90%
1Q
8.31%
Jan 2017
100.74%
Name

Olympus Corp

Chart & Performance

D1W1MN
XJPX:7733 chart
P/E
19.37
P/S
2.29
EPS
104.69
Div Yield, %
0.89%
Shrs. gr., 5y
-2.67%
Rev. gr., 5y
4.58%
Revenues
997.33b
+7.73%
978,127,000,0001,061,786,000,0001,128,875,000,000980,803,000,000883,086,000,000847,105,000,000848,548,000,000743,851,000,000713,286,000,000764,671,000,000804,578,000,000748,050,000,000786,497,000,000793,862,000,000797,411,000,000730,544,000,000868,867,000,000881,923,000,000925,752,000,000997,332,000,000
Net income
117.86b
-51.41%
28,564,000,00047,799,000,00057,969,000,000-114,810,000,00047,763,000,0007,381,000,000-48,985,000,0008,020,000,00013,627,000,000-8,737,000,00062,594,000,00078,191,000,00057,064,000,0008,147,000,00051,670,000,00012,918,000,000115,742,000,000143,432,000,000242,566,000,000117,855,000,000
CFO
190.46b
+349.58%
49,034,000,000108,400,000,00089,006,000,00041,628,000,00076,245,000,00032,917,000,00030,889,000,00025,233,000,00072,388,000,00066,811,000,00048,621,000,00090,194,000,00095,146,000,00066,943,000,000133,544,000,000124,122,000,000169,729,000,00098,490,000,00042,365,000,000190,463,000,000
Dividend
Mar 30, 202630 JPY/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Olympus Corporation manufactures and sells precision machineries and instruments worldwide. It operates through four segments: Endoscopic Solutions Business, Therapeutic Solutions Business, Scientific Solutions Business, and Others. The Endoscopic Solutions Business segment offers gastrointestinal and surgical endoscopes, endoscopy system, and repair services. The Therapeutic Solutions Business segment provides urology, gynecology, ear, nose, and throat products; endo-therapy and energy devices; and surgical single-use devices. The Scientific Solutions Business segment offers biological and industrial microscopes, industrial endoscopes and videoscopes, non-destructive testing equipment, and X-ray fluorescence (XRF) analyzers. The Others segment offers biomedical materials and orthopedic equipment. The company also offers medical devices, such as surgical microscopes, endoscope reprocessors, electrosurgical devices, and respiratory-endotherapy devices, as well as system integration and maintenance/services. The company was formerly known as Olympus Optical Co., Ltd. and changed its name to Olympus Corporation in October 2003. Olympus Corporation was founded in 1919 and is headquartered in Tokyo, Japan.
URL
https://www.olympus.co.jp/
IPO date
May 16, 1949
Employees
32,844
Domiciled in
JP
Incorporated in
JP

Valuation

Title
JPY in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑032024‑032023‑032022‑032021‑032020‑032019‑032018‑032017‑032016‑03
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT